| (USD) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 7.22M | — |
| Operating expense | — | — |
| Net income | -13.04M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, CASIF returned -94.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -84.8% |
| 1 year | -94.5% |
| 5 years | -99.2% |
| 10 years | -98.9% |
| All-time high | $10,835.00 (Feb 2000) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in CASIF would be worth today ›No. CASI Pharmaceuticals, Inc. has not paid a dividend in the past 12 months.
CASI Pharmaceuticals, Inc. is part of the Healthcare sector.
CASI Pharmaceuticals, Inc. has a market cap of 2.65M USD, based on the latest quote.
